Cargando…

Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS)

Detalles Bibliográficos
Autores principales: Altschuler, Eric L., Kast, Richard E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177090/
https://www.ncbi.nlm.nih.gov/pubmed/32344275
http://dx.doi.org/10.1016/j.mehy.2020.109774
_version_ 1783525143835836416
author Altschuler, Eric L.
Kast, Richard E.
author_facet Altschuler, Eric L.
Kast, Richard E.
author_sort Altschuler, Eric L.
collection PubMed
description
format Online
Article
Text
id pubmed-7177090
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71770902020-04-23 Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS) Altschuler, Eric L. Kast, Richard E. Med Hypotheses Article Elsevier Ltd. 2020-08 2020-04-23 /pmc/articles/PMC7177090/ /pubmed/32344275 http://dx.doi.org/10.1016/j.mehy.2020.109774 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Altschuler, Eric L.
Kast, Richard E.
Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS)
title Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS)
title_full Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS)
title_fullStr Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS)
title_full_unstemmed Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS)
title_short Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS)
title_sort dapsone, colchicine and olanzapine as treatment adjuncts to prevent covid-19 associated adult respiratory distress syndrome (ards)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177090/
https://www.ncbi.nlm.nih.gov/pubmed/32344275
http://dx.doi.org/10.1016/j.mehy.2020.109774
work_keys_str_mv AT altschulerericl dapsonecolchicineandolanzapineastreatmentadjunctstopreventcovid19associatedadultrespiratorydistresssyndromeards
AT kastricharde dapsonecolchicineandolanzapineastreatmentadjunctstopreventcovid19associatedadultrespiratorydistresssyndromeards